Načítá se...
Will Remdesivir Reshape Cardiovascular Practice in COVID 19 Era?
Infection with the novel coronavirus, SARS-CoV2, produces the clinical syndrome COVID-19. COVID-19 is a systemic illness inducing hyperinflammation and cytokine storm affecting multiple organs including the myocardium which is reflected in elevated cardiac biomarkers such as troponin, lactate dehydr...
Uloženo v:
| Vydáno v: | Int J Angiol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Thieme Medical Publishers, Inc.
2021
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8159607/ https://ncbi.nlm.nih.gov/pubmed/34054274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1721403 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|